The American Gastroenterological Association has released updated guidelines for Barrett’s esophagus, moving toward risk-based, personalized monitoring. The recommendations detail when to increase, ...

Clinical studies from Mayo Clinic researchers demonstrate the TissueCypher test provides improved risk stratification and influences risk-aligned surveillance decisions in clinical practice, with one ...

Dr Sethi says the cancer often starts with mild trouble swallowing, which most people ignore because it feels minor at first.

Reward Picks Lucid Diagnostics (NASDAQ:LUCD) reported first-quarter 2026 EsoGuard test volume above its pre-Medicare target range, while management ...

Gastroenterology continues to evolve rapidly as advances in colorectal cancer prevention, inflammatory bowel disease research, microbiome science and outpatient digestive care reshape the specialty.

Why it matters: Untreated GERD can cause long-term damage, including Barrett’s esophagus, which increases the risk of esophageal cancer. Everyday prevention: Avoid trigger foods, eat smaller meals, ...

Acidity is often treated casually, but repeated symptoms may signal deeper digestive issues such as GERD. This article ...

"We performed 3,177 EsoGuard tests in the first quarter of this year and this generated revenue of $1.3 million." (Chairman & CEO Lishan Aklog) "We also importantly strengthened our balance sheet with ...

Did you think acidity and acid reflux are the same If yes you are wrong While these sound similar and describe a common issue ...

Participants who underwent cTIF procedure also experienced less dysphagia ...

Detailed price information for Castle Biosciences Inc (CSTL-Q) from The Globe and Mail including charting and trades.

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique ...